Npffr2 contributes to the malignancy of hepatocellular carcinoma development by activating rhoa/yap signaling

HIGHLIGHTS

• who: Yuna Shin and colleagues from the Seoul, Republic of Korea and, University of Science and Technology have published the Article: NPFFR2 Contributes to the Malignancy of Hepatocellular Carcinoma Development by Activating RhoA/YAP Signaling, in the Journal: Cancers 2022, 14, x FOR PEER REVIEW of /2022/
• what: The authors investigated the role of NPFFR2 in HCC. The authors report that NPFFR2, a neuropeptide GPCR, overexpressed in HCC, is an indicator of poor prognosis of HCC, and its expression is increased in more advanced stages. For the first time, the authors report that NPFFR2 acts . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.